Search

everythinglearnresearchcommunity

for

Search:↓

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

Women with PCOS-related infertility can often conceive with treatments like clomiphene and metformin, but managing pregnancy complications is important.

Oral isotretinoin was recommended for a 21-year-old woman with severe acne.

Spironolactone plus finasteride works better for treating hirsutism.

Taking a small dose of prednisone before menstruation can almost completely prevent premenstrual acne with few side effects.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

Hair loss drugs like finasteride may cause lasting sexual and mood side effects, and more research is needed to understand these risks.

Rivaroxaban may cause hair loss.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

The new oral testosterone pill normalized testosterone levels and lowered SHBG in men with low testosterone.

New oral testosterone formulations show potential for safer, effective hormone replacement in men with low testosterone.

A woman's hair changed to a dry, tangled texture that's hard to comb after treatment with spironolactone, suggesting the medication might cause such hair changes.

Women with PCOS may have a higher risk of respiratory and ear infections due to slower nasal mucociliary clearance.

Nourkrin® with Marilex® may increase hair count by 35.7% in postpartum hair loss.

Anti-androgens are safe and effective for treating moderate to severe adult female acne.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

The study found that prescribing patterns for Cyproterone Acetate/Ethinylestradiol in Italy did not significantly change after EMA recommendations.

The review suggests a comprehensive approach to treat hirsutism, focusing on hair removal, medication, and managing emotional effects.

The document says that common skin conditions in adult women can be treated effectively, with acne being the most common and early-detected melanoma having a high survival rate.

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

Spironolactone may cause sexual pain and arousal issues in women, which can improve after stopping the drug and using hormone cream.

Minoxidil and spironolactone slow hair loss in women.

Melasma is a skin condition linked to female hormones, genetics, UV exposure, and certain medications, but not to pituitary, adrenal, or thyroid diseases.

Women using hair relaxers with alopecia had lower zinc levels, suggesting zinc deficiency might contribute to hair loss.

Wiesbaden 30C effectively reduces hair fall and improves hair growth in young adults with Telogen Effluvium.

Combining hysteroscopy with Diane-35 improves outcomes and reduces recurrence of endometrial polyps.

Isoflavone may help manage PCOS symptoms, but its effectiveness is uncertain.

Removing the outer skin layer increases drug absorption and offers non-invasive treatment options, with some methods allowing for quick skin recovery.